F.D.A. Approves New Obesity Drug Tirzepatide That Will Compete With Wegovy
F.D.A. Approves New Obesity Drug Tirzepatide That Will Compete With Wegovy
1 year ago
153
Zepbound, which is already sold by Eli Lilly arsenic the diabetes attraction Mounjaro, was shown to trim patients’ value by arsenic overmuch arsenic one-fifth successful cause trials.